185 related articles for article (PubMed ID: 38124015)
1. Neural Network Connectivity Following Opioid Dependence is Altered by a Common Genetic Variant in the µ-Opioid Receptor,
Xie Y; Brynildsen JK; Windisch K; Blendy JA
J Neurosci; 2024 Feb; 44(6):. PubMed ID: 38124015
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
3. Neurobehavioral effects of neonatal opioid exposure in mice: Influence of the OPRM1 SNP.
Robinson SA; Jones AD; Brynildsen JK; Ehrlich ME; Blendy JA
Addict Biol; 2020 Sep; 25(5):e12806. PubMed ID: 31267641
[TBL] [Abstract][Full Text] [Related]
4. Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function.
Mague SD; Port RG; McMullen ME; Carlson GC; Turner JR
Neuropharmacology; 2015 Oct; 97():426-35. PubMed ID: 25986698
[TBL] [Abstract][Full Text] [Related]
5. Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry.
Popova D; Desai N; Blendy JA; Pang ZP
J Neurosci; 2019 Jul; 39(29):5685-5696. PubMed ID: 31109961
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of the μ opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G.
Wang YJ; Huang P; Ung A; Blendy JA; Liu-Chen LY
Neuroscience; 2012 Mar; 205():178-84. PubMed ID: 22240251
[TBL] [Abstract][Full Text] [Related]
7. Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference.
Collins D; Zhang Y; Blendy J; Kreek MJ
Neuropharmacology; 2020 May; 167():107864. PubMed ID: 31778689
[TBL] [Abstract][Full Text] [Related]
8. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
9. Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior.
Mague SD; Isiegas C; Huang P; Liu-Chen LY; Lerman C; Blendy JA
Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10847-52. PubMed ID: 19528658
[TBL] [Abstract][Full Text] [Related]
10. Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.
Zhang Y; Picetti R; Butelman ER; Ho A; Blendy JA; Kreek MJ
Neuropsychopharmacology; 2015 Mar; 40(5):1091-100. PubMed ID: 25336208
[TBL] [Abstract][Full Text] [Related]
11. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
12. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
Bagher AM; Hareeri RH
J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
[TBL] [Abstract][Full Text] [Related]
13. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.
Xu J; Lu Z; Xu M; Pan L; Deng Y; Xie X; Liu H; Ding S; Hurd YL; Pasternak GW; Klein RJ; Cartegni L; Zhou W; Pan YX
J Neurosci; 2014 Aug; 34(33):11048-66. PubMed ID: 25122903
[TBL] [Abstract][Full Text] [Related]
14. Oprm1 A112G, a single nucleotide polymorphism, alters expression of stress-responsive genes in multiple brain regions in male and female mice.
Collins D; Randesi M; da Rosa JC; Zhang Y; Kreek MJ
Psychopharmacology (Berl); 2018 Sep; 235(9):2703-2711. PubMed ID: 30027498
[TBL] [Abstract][Full Text] [Related]
15. Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G.
Wang YJ; Huang P; Blendy JA; Liu-Chen LY
Addict Biol; 2014 May; 19(3):354-61. PubMed ID: 22862850
[TBL] [Abstract][Full Text] [Related]
16. The Influence of OPRM1 A118G Polymorphism on the Dosage of Morphine in Patients with Advanced Liver Cancer.
Cheng H; Chu X; Yi S
J Coll Physicians Surg Pak; 2021 Nov; 31(11):1375-1377. PubMed ID: 34689504
[TBL] [Abstract][Full Text] [Related]
17. Effect of Selective Lesions of Nucleus Accumbens µ-Opioid Receptor-Expressing Cells on Heroin Self-Administration in Male and Female Rats: A Study with Novel
Bossert JM; Mejias-Aponte CA; Saunders T; Altidor L; Emery M; Fredriksson I; Batista A; Claypool SM; Caldwell KE; Reiner DJ; Chow JJ; Foltz M; Kumar V; Seasholtz A; Hughes E; Filipiak W; Harvey BK; Richie CT; Vautier F; Gomez JL; Michaelides M; Kieffer BL; Watson SJ; Akil H; Shaham Y
J Neurosci; 2023 Mar; 43(10):1692-1713. PubMed ID: 36717230
[TBL] [Abstract][Full Text] [Related]
18. Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration.
Zhang Y; Collins D; Butelman ER; Blendy JA; Kreek MJ
Neuropharmacology; 2020 Dec; 181():108351. PubMed ID: 33031806
[TBL] [Abstract][Full Text] [Related]
19. The A118G single-nucleotide polymorphism in OPRM1 is a risk factor for asthma severity.
Kawakami K; Miyasaka T; Nakamura Y; Metoki H; Miyata S; Sato M; Sora I; Yamauchi K; Kawakami K; Blendy JA; Kawano T; Shimokawa H; Takayanagi M; Ohno I; Takahashi T
Allergol Int; 2022 Jan; 71(1):55-65. PubMed ID: 34688555
[TBL] [Abstract][Full Text] [Related]
20. Mouse model of OPRM1 (A118G) polymorphism increases sociability and dominance and confers resilience to social defeat.
Briand LA; Hilario M; Dow HC; Brodkin ES; Blendy JA; Berton O
J Neurosci; 2015 Feb; 35(8):3582-90. PubMed ID: 25716856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
